✦ LIBER ✦

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

✍ Scribed by Lance L. Stein; Mamie H. Dong; Rohit Loomba

Publisher: Springer Healthcare Communications
Year: 2009
Tongue: English
Weight: 238 KB
Volume: 26
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-009-0072-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin sensitizers in nonalcoholic stea

Insulin sensitizers in nonalcoholic steatohepatitis

✍ Stephen A. Harrison; Steven Schenker; Kenneth Cusi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Comparative redox status in alcoholic li

Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease

✍ Payal Bhardwaj; Kaushal Madan; Sandeep Thareja; Yogendra Kumar Joshi; Anoop Sara 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

Therapeutic trials in nonalcoholic steat

Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues

✍ Vlad Ratziu; Stephen Caldwell; Brent A. Neuschwander-Tetri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Insulin sensitizers are attractive candidate therapies for nonalcoholic steatohepatitis mainly because of the strong association between this disease and insulin resistance. This review provides a critical overview of the mechanisms of action, clinical trial results, and safety issues of metformin a

Fatty Liver Disease: Predictors of Nonal

Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Gallbladder Disease in Morbid Obesity

✍ Phui-Ly Liew; Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Wei-Yu Chen; Chia-Lang Fang; M 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 150 KB

Nonalcoholic fatty liver disease and non

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

✍ Raj Vuppalanchi; Naga Chalasani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Nonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease in the western world. It is now recognized that these patients have myriad of important co-morbidities (e.g., diabetes, hypothyroidism and metabolic syndrome). The workup of patients with suspected NAFL

Genes and nonalcoholic fatty liver disea

Genes and nonalcoholic fatty liver disease

✍ Nimantha Mark Wilfred de Alwis; Christopher Paul Day 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 155 KB